Health - Health - Senior latest news

Sepracor Inc. (Nasdaq: SEPR) announced the presentation of LUNESTA ® brand eszopiclone Phase IV study data at the 21st European College of Neuropsychopharmacology (ECNP) Congress in Barcelona. The poster presentations reflected results from a 12-week, double-blind, randomized safety and efficacy study of 388 elderly patients (65-85 years of age) who were administered either LUNESTA 2 mg or placebo nightly.

The new york state Department of Civil Service this fall is planning to launch an investigation to ensure that the 1.2 million state employees, dependents and retirees who receive health insurance under the New York State Health Insurance Program are eligible for their coverage, the

Title: Scientists Discover How Osteoarthritis Destroys CartilageCategory: health newscreated: 9/5/2008 2:00:00 amlast Editorial review: 9/5/2008

Dr. Forrest Scogin , an expert in mental health and aging and professor of clinical psychology at The University of Alabama, has won the M. Powell Lawton Distinguished Contribution Award for Applied Gerontology from the American Psychological Association. The award was given at the APA's convention last month in Boston.

Title: Research Unveils Earliest Cell Changes in Down SyndromeCategory: health newscreated: 9/5/2008 2:00:00 amlast Editorial review: 9/5/2008

Title: 'Street' Drug Use Down, Rx Drug Abuse Rising: U.S. ReportCategory: health newscreated: 9/5/2008 2:00:00 amlast Editorial review: 9/5/2008

Title: Even Kids With Known Allergies Can Be Safely VaccinatedCategory: health newscreated: 9/5/2008 2:00:00 amlast Editorial review: 9/5/2008

Title: Most U.S. Kids Getting Recommended VaccinationsCategory: health newscreated: 9/5/2008 2:00:00 amlast Editorial review: 9/5/2008

Title: Deaths Heighten Arthritis Drugs WarningCategory: health newscreated: 9/5/2008Last Editorial review: 9/5/2008

Title: C-Section Affects Moms' Response to BabyCategory: health newscreated: 9/5/2008Last Editorial review: 9/5/2008